Bruker (BRKR) Net Profit Margin: History & Chart

Bruker Corporation(BRKR)

Medical - Devices · Billerica, MA

$60.10-3.76 (-5.89%)

Delayed quote: Oct 6, 2026, 10:20 AM EDT

About Bruker Corporation

Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.

Billerica, MA

11,085 employees

www.bruker.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Frank H. Laukien

View full financials

BRKR Net Profit Margin Metrics

NET PROFIT MARGIN

-2.03%

NET PROFIT MARGIN AVG TTM

-1.55%

NET PROFIT MARGIN AVG 3Y

2.40%

NET PROFIT MARGIN AVG 5Y

6.94%

NET PROFIT MARGIN AVG 10Y

7.13%

NET PROFIT MARGIN AVG 15Y

6.32%

NET PROFIT MARGIN AVG 20Y

6.49%

CURRENT VS TTM AVG

-30.71%

CURRENT VS 3Y AVG

-184.66%

CURRENT VS 5Y AVG

-129.25%

CURRENT VS 10Y AVG

-128.47%

CURRENT VS 15Y AVG

-132.12%

CURRENT VS 20Y AVG

-131.29%

SECTOR MEDIAN · HEALTHCARE

0.00%

median of 570 covered companies

CURRENT VS SECTOR MEDIAN

N/A

vs the sector median at left

NAME	MARKET CAP	NET PROFIT MARGIN	TTM	3Y	5Y
Bruker Corporation (BRKR)	$9.15B	-2.03%	-1.55%	2.40%	6.94%
Insulet Corp. (PODD)vs ›	$9.31B	12.29%	14.66%	10.46%	7.35%
Krystal Biotech, Inc. (KRYS)vs ›	$9.49B	54.82%	41.66%	26.22%	17.48%
Bruker Corporation (BRKRP)vs ›	$8.94B	-2.03%	1.55%	7.31%	8.11%
Henry Schein, Inc. (HSIC)vs ›	$9.72B	2.96%	3.05%	3.43%	3.79%
Axsome Therapeutics, Inc. (AXSM)vs ›	$8.73B	-24.68%	-51.58%	-141.39%	-94.26%
The Ensign Group, Inc. (ENSG)vs ›	$10.02B	6.90%	6.89%	6.71%	6.89%
Molina Healthcare, Inc. (MOH)vs ›	$10.07B	-0.02%	1.97%	2.41%	2.58%
Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›	$8.54B	-47.79%	-8441.28%	-4260.06%	-2873.03%
Bio-Rad Laboratories, Inc. (BIO)vs ›	$10.09B	8.59%	-21.22%	-48.94%	16.61%

NAME

MARKET CAP

NET PROFIT MARGIN

TTM

Bruker Corporation (BRKR)

$9.15B

-2.03%

-1.55%

2.40%

6.94%

Insulet Corp. (PODD)vs ›

$9.31B

12.29%

14.66%

10.46%

7.35%

Krystal Biotech, Inc. (KRYS)vs ›

$9.49B

54.82%

41.66%

26.22%

17.48%

Bruker Corporation (BRKRP)vs ›

$8.94B

-2.03%

1.55%

7.31%

8.11%

Henry Schein, Inc. (HSIC)vs ›

$9.72B

2.96%

3.05%

3.43%

3.79%

Axsome Therapeutics, Inc. (AXSM)vs ›

$8.73B

-24.68%

-51.58%

-141.39%

-94.26%

The Ensign Group, Inc. (ENSG)vs ›

$10.02B

6.90%

6.89%

6.71%

6.89%

Molina Healthcare, Inc. (MOH)vs ›

$10.07B

-0.02%

1.97%

2.41%

2.58%

Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›

$8.54B

-47.79%

-8441.28%

-4260.06%

-2873.03%

Bio-Rad Laboratories, Inc. (BIO)vs ›

$10.09B

8.59%

-21.22%

-48.94%

16.61%

Net Profit Margin FAQ

What is the net profit margin for Bruker Corporation (BRKR)?

The net profit margin for BRKR stock is -2.03%.

Is Bruker Corporation's net profit margin high or low?

The net profit margin of -2.03% is 129% below its 5-year average of 6.94%, near the low end of its 5-year range (-6.93%–24.05%).

What is the TTM average net profit margin for Bruker Corporation (BRKR)?

The TTM average net profit margin for BRKR stock is -1.55%.

What is the 3Y average net profit margin for Bruker Corporation (BRKR)?

The 3Y average net profit margin for BRKR stock is 2.40%.

What is the 5Y average net profit margin for Bruker Corporation (BRKR)?

The 5Y average net profit margin for BRKR stock is 6.94%.

What is the 10Y average net profit margin for Bruker Corporation (BRKR)?

The 10Y average net profit margin for BRKR stock is 7.13%.

What is the 15Y average net profit margin for Bruker Corporation (BRKR)?

The 15Y average net profit margin for BRKR stock is 6.32%.

What is the 20Y average net profit margin for Bruker Corporation (BRKR)?

The 20Y average net profit margin for BRKR stock is 6.49%.

DATE	NET PROFIT MARGIN
2026-06-30	-6.20%
2026-03-31	1.75%
2025-12-31	2.66%
2025-09-30	-6.93%
2025-06-30	0.95%
2025-03-31	2.17%
2024-12-31	1.40%
2024-09-30	4.73%
2024-06-30	0.95%
2024-03-31	7.05%
2023-12-31	24.05%
2023-09-30	11.86%
2023-06-30	8.37%
2023-03-31	11.16%
2022-12-31	13.75%
2022-09-30	13.79%
2022-06-30	8.41%
2022-03-31	10.35%
2021-12-31	11.08%
2021-09-30	14.30%
2021-06-30	10.09%
2021-03-31	10.22%
2020-12-31	10.98%
2020-09-30	10.62%
2020-06-30	5.68%
2020-03-31	2.48%
2019-12-31	11.44%
2019-09-30	11.76%
2019-06-30	7.45%
2019-03-31	6.68%
2018-12-31	14.11%
2018-09-30	9.30%
2018-06-30	7.03%
2018-03-31	6.25%
2017-12-31	-0.64%
2017-09-30	8.49%
2017-06-30	5.64%
2017-03-31	5.61%
2016-12-31	14.67%
2016-09-30	11.81%
2016-06-30	3.90%
2016-03-31	6.29%
2015-12-31	12.84%
2015-09-30	2.98%
2015-06-30	5.53%
2015-03-31	1.84%
2014-12-31	5.14%
2014-09-30	1.31%
2014-06-30	3.59%
2014-03-31	2.05%
2013-12-31	6.38%
2013-09-30	3.78%
2013-06-30	5.03%
2013-03-31	1.37%
2012-12-31	2.47%
2012-09-30	8.87%
2012-06-30	2.35%
2012-03-31	3.72%
2011-12-31	8.23%
2011-09-30	4.73%
2011-06-30	5.51%
2011-03-31	3.17%
2010-12-31	7.04%
2010-09-30	8.83%
2010-06-30	7.51%
2010-03-31	5.80%
2009-12-31	11.87%
2009-09-30	6.19%
2009-06-30	5.11%
2009-03-31	3.56%
2008-12-31	8.27%
2008-09-30	7.35%
2008-06-30	6.96%
2008-03-31	-0.29%
2007-12-31	7.63%
2007-09-30	6.58%
2007-06-30	4.08%
2007-03-31	3.51%
2006-12-31	7.16%
2006-09-30	2.84%
2006-06-30	0.62%
2006-03-31	1.04%
2005-12-31	2.32%
2005-09-30	1.53%
2005-06-30	0.40%
2005-03-31	0.56%
2004-12-31	-1.71%
2004-09-30	-4.09%
2004-06-30	-7.30%
2004-03-31	1.52%
2003-12-31	0.42%
2003-09-30	-23.26%
2003-06-30	-0.68%
2003-03-31	-3.17%
2002-12-31	-14.03%
2002-09-30	5.63%

DATE

NET PROFIT MARGIN

2026-06-30

-6.20%

2026-03-31

1.75%

2025-12-31

2.66%

2025-09-30

-6.93%

2025-06-30

0.95%

2025-03-31

2.17%

2024-12-31

1.40%

2024-09-30

4.73%

2024-06-30

0.95%

2024-03-31

7.05%

2023-12-31

24.05%

2023-09-30

11.86%

2023-06-30

8.37%

2023-03-31

11.16%

2022-12-31

13.75%

2022-09-30

13.79%

2022-06-30

8.41%

2022-03-31

10.35%

2021-12-31

11.08%

2021-09-30

14.30%

2021-06-30

10.09%

2021-03-31

10.22%

2020-12-31

10.98%

2020-09-30

10.62%

2020-06-30

5.68%

2020-03-31

2.48%

2019-12-31

11.44%

2019-09-30

11.76%

2019-06-30

7.45%

2019-03-31

6.68%

2018-12-31

14.11%

2018-09-30

9.30%

2018-06-30

7.03%

2018-03-31

6.25%

2017-12-31

-0.64%

2017-09-30

8.49%

2017-06-30

5.64%

2017-03-31

5.61%

2016-12-31

14.67%

2016-09-30

11.81%

2016-06-30

3.90%

2016-03-31

6.29%

2015-12-31

12.84%

2015-09-30

2.98%

2015-06-30

5.53%

2015-03-31

1.84%

2014-12-31

5.14%

2014-09-30

1.31%

2014-06-30

3.59%

2014-03-31

2.05%

2013-12-31

6.38%

2013-09-30

3.78%

2013-06-30

5.03%

2013-03-31

1.37%

2012-12-31

2.47%

2012-09-30

8.87%

2012-06-30

2.35%

2012-03-31

3.72%

2011-12-31

8.23%

2011-09-30

4.73%

2011-06-30

5.51%

2011-03-31

3.17%

2010-12-31

7.04%

2010-09-30

8.83%

2010-06-30

7.51%

2010-03-31

5.80%

2009-12-31

11.87%

2009-09-30

6.19%

2009-06-30

5.11%

2009-03-31

3.56%

2008-12-31

8.27%

2008-09-30

7.35%

2008-06-30

6.96%

2008-03-31

-0.29%

2007-12-31

7.63%

2007-09-30

6.58%

2007-06-30

4.08%

2007-03-31

3.51%

2006-12-31

7.16%

2006-09-30

2.84%

2006-06-30

0.62%

2006-03-31

1.04%

2005-12-31

2.32%

2005-09-30

1.53%

2005-06-30

0.40%

2005-03-31

0.56%

2004-12-31

-1.71%

2004-09-30

-4.09%

2004-06-30

-7.30%

2004-03-31

1.52%

2003-12-31

0.42%

2003-09-30

-23.26%

2003-06-30

-0.68%

2003-03-31

-3.17%

2002-12-31

-14.03%

2002-09-30

5.63%

Net Profit Margin: -2.03%

BRKR Profit Margin

BRKR Average Net Profit Margin Chart

BRKR Current vs Average Net Profit Margin Chart

BRKR Net Profit Margin Metrics

BRKR Competitors' Net Profit Margin

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin FAQ

BRKR Net Profit Margin History

Related Metrics